We report a case of coronavirus disease 2019 (COVID-19) after haploidentical transplantation with acute graft-versus-host disease (aGVHD). COVID-19 and aGVHD were improved under treatment with arbidol, remdesivir, methylprednisolone, and ruxolitinib. However, eventually, the patient died of septic shock and multiple organ failure. It was concluded that the disease condition of this COVID-19 patient after transplantation was serious, complex, and variable, with poor prognosis.
第一作者单位：[1]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hematol, Wuhan 430022, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Han Dan,Sun Yuqian,Xie Rong,et al.A Case of Severe COVID-19 in a Patient with Acute Graft-versus-Host Disease after Haploidentical Transplantation[J].CASE REPORTS IN HEMATOLOGY.2021,2021:doi:10.1155/2021/8878803.
APA：
Han, Dan,Sun, Yuqian,Xie, Rong,Zhu, Xiaojian&Zhong, Zhaodong.(2021).A Case of Severe COVID-19 in a Patient with Acute Graft-versus-Host Disease after Haploidentical Transplantation.CASE REPORTS IN HEMATOLOGY,2021,
MLA：
Han, Dan,et al."A Case of Severe COVID-19 in a Patient with Acute Graft-versus-Host Disease after Haploidentical Transplantation".CASE REPORTS IN HEMATOLOGY 2021.(2021)
